Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 01-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 160 | 10 | 800 | 830 |
| Depreciation Amortization | 110 | 390 | 140 | 140 | 180 |
| Income taxes - deferred | N/A | -338 | N/A | N/A | N/A |
| Accounts receivable | N/A | -282 | N/A | N/A | N/A |
| Other Working Capital | 910 | 590 | -720 | -1 | 180 |
| Other Operating Activity | 370 | 380 | 90 | 61 | -70 |
| Operating Cash Flow | $1,390 | $899 | $-480 | $1,000 | $1,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,850 | -897 | -590 | -60 | -50 |
| Other Investing Activity | 0 | -701 | 0 | 0 | 0 |
| Investing Cash Flow | $-2,850 | $-1,598 | $-590 | $-60 | $-50 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -178 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 11 | -170 | -910 | -430 |
| Financing Cash Flow | $N/A | $-167 | $-170 | $-910 | $-430 |
| Exchange Rate Effect | -2 | N/A | 0 | 0 | 0 |
| Beginning Cash Position | N/A | 5,087 | 5,080 | 4,430 | 3,790 |
| End Cash Position | N/A | 4,221 | 3,830 | 4,450 | 4,430 |
| Net Cash Flow | $-1,462 | $-865 | $-1,240 | $20 | $630 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,390 | 899 | -480 | 1,000 | 1,120 |
| Capital Expenditure | N/A | -897 | N/A | N/A | N/A |
| Free Cash Flow | 1,390 | 2 | -480 | 1,000 | 1,120 |